New modified 2-aminobenzimidazole nucleosides: Synthesis and evaluation of their activity against herpes simplex virus type 1

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2484-2487. doi: 10.1016/j.bmcl.2017.03.100. Epub 2017 Apr 1.

Abstract

Using the enzymatic transglycosylation reaction β-d-ribo- and 2'-deoxyribofuranosides of 2-amino-5,6-difluorobenzimidazole nucleosides have been synthesized. 2-Amino-5,6-difluoro-benzimidazole riboside proved to exhibit a selective antiviral activity (selectivity index >32) against a wild strain of the herpes simplex virus type 1, as well as towards virus strains that are resistant to acyclovir, cidofovir, and foscarnet. We believe that this compound might be used for treatment of herpes infections in those cases, when acyclovir is not efficient.

Keywords: Antiviral activity; Benzimidazoles; Fluorinated compounds; Nucleoside phosphorylases; Nucleosides; Transglycosylation reaction.

MeSH terms

  • Acyclovir / pharmacology
  • Antiviral Agents / chemical synthesis*
  • Antiviral Agents / pharmacology
  • Benzimidazoles / chemistry*
  • Cidofovir
  • Cytosine / analogs & derivatives
  • Cytosine / pharmacology
  • Drug Resistance, Viral / drug effects
  • Foscarnet / pharmacology
  • Herpesvirus 1, Human / drug effects
  • Humans
  • Nucleosides / chemistry*
  • Nucleosides / pharmacology
  • Organophosphonates / pharmacology

Substances

  • Antiviral Agents
  • Benzimidazoles
  • Nucleosides
  • Organophosphonates
  • Foscarnet
  • Cytosine
  • 2-aminobenzimidazole
  • Cidofovir
  • Acyclovir